For adolescents (ages 12 to 17): Continuation of therapy: The patient is between 12 and 17 years of age, and
GLP-1 RAs are a promising treatment option for patients whose disease is characterized by a combination of metabolic and immune dysregulation
[3] Consider switching GLP-1 medications
It continues to be the preferred choice in many traditional Latin American markets, where yerba mate is consumed daily and affordability is critical to household purchasing decisions
Liu was very open in term of answering any questions that I had and was part of my journey
For a 14-year-old specifically, providers must confirm BMI 95th percentile for age and sex, assess for underlying medical conditions, evaluate medication interactions, and rule out contraindications including personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2)